Selected Publications

Williams NO, Quiroga D, Johnson C, Brufsky A, Chambers M, Bhattacharya S, Patterson M, Sardesai SD, Stover D, Lustberg M, Noonan AM, Cherian M, Bystry DM, Hill KL, Chen M, Phelps MA, Grever M, Stephens JA, Ramaswamy B, Carson WE 3rd, Wesolowski R.: Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer. Ther Adv Med Oncol. December 25 2023.

Russell J. Schilder, Mark S. Shahin, Mitchell Edelson, Norman G. Rosenblum, Ashley Douglas, Saveri Bhattacharya, Tarek Sahmoud, Elizabeth Burton, Avnish K Bhatia: OATH trial: A phase II clinical trial evaluating the combination of onapristone with anastrozole for women with hormone receptor positive endometrial cancer—Preliminary results. American Society of Clinical Oncology Annual Meeting, Chicago, IL 41(suppl 16; abstr 5601), June 2023 Notes: "Poster Presentation"

Williams W, Dakhil SR, Calfa C, Holmes JP, Bhattacharya S, Lukas J, Tan-Chui E, Peoples G, Sunkar, V, Lacher, M., Wiseman, C.L: Overall survival following treatment with a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer. Cancer Research, San Antonio Breast Cancer Symposium, San Antonio, TX 82(4_Supplement): P2-14-02, February 2022 Notes: "Poster Presentation"

Tara Hyder, Saveri Bhattacharya, Kristine Gade, Azadeh Nasrazadani, Adam M Brufsky: Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer. Breast Cancer 30(13): 199-211, March 2021.

Chun Wang, Zhaomei Mu, Zhong Ye, Zhenchao Zhang, Maysa M Abu-Khalaf, Daniel P Silver, Juan P Palazzo, Geetha Jagannathan, Frederick M Fellin, Saveri Bhattacharya, Rebecca J Jaslow, Theodore N Tsangaris, Adam Berger, Manish Neupane, Terrence P Cescon, AnaMaria Lopez, Kaelan Yao, Weelic Chong, Brian Lu, Ronald E Myers, Lifang Hou, Qiang Wei, Bingshan Li, Massimo Cristofanilli, Hushan Yang: Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors. Breast Cancer Res Treat 181(3), June 2020.

Lazar, M., Bhattacharya, S., Tsangaris, T.: Management of Recurrent and Metastatic Breast Cancer. Breast Chapter in Current Surgical Therapy Page: 706-710, June 2020 Notes: 13th Edition by J. L. Cameron and A.M. Cameron, Elsevier, Inc: Philadelphia.

William Williams, Shaker R. Dakhil, Carmen Julia Calfa, Jarrod P. Holmes, Saveri Bhattacharya, Jason Jerome Lukas, Elizabeth Tan-Chiu, George Earl Peoples, Vivekananda Sunkari, Markus Lacher, Charles L. Wiseman: Breast cancer grade and clinical benefit in patients with advanced breast cancer treated with an engineered whole tumor cell-targeted immunotherapy alone or in combination with checkpoint inhibition. American Society of Clinical Oncology Annual Meeting, Chicago, IL 38(suppl; abstr 3033), June 2020 Notes: "Poster Presentation"

Bhattacharya, S., Schiewer, M., Murphy, R.C., Anne, P.R., Simone, N., Bar Ad, V., Abu Khalaf, M., Silver, D.P., Jaslow, R., Fellin, F.M., Zibelli, A.M., Lopez, A., Berger, A., Tsangaris, T.N., Lazar, M.A., Willis, A.I., Stauffer, P., Hurwitz, M.D. A : Pilot trial of Hyperthermia in Combination with Olaparib in Breast Cancer Patients with Chest wall Recurrences.” San Antonio Breast Cancer Symposium, San Antonio, TX Dec 12 2019 Notes: Poster Presentation

Williams, W. V., Dakhil, D.S., Holmes, J.P. Bhattacharya, S., Calfa, C., Kundra, A., Adams, D., DaSilva, D., Cornfeld, M., Leopold, L., Peoples, G.E., Sunkari, V., Lacher, M., Wiseman, C.L.: Efficacy and safety of a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer alone and in combination with immune checkpoint inhibitors" San Antonio Breast Cancer Symposium, San Antonio, TX Dec 12 2019 Notes: Poster presentation.

Wesolowski, R., Brufsky, A., Chambers, M., Bhattacharya, S., Lustberg, M., VanDeusen, J. V., Sardesai, S., O Williams, N., Noonan, A.M., Phelps, M., Grever, M., Stephens, J., Carson, W.E., Ramaswamy, B.: Phase 1b study of heat shock protein 90 inhibitor, onalespib in combination with paclitaxel in patients with advanced, triple negative breast cancer NCT02474173). European Society of Medical Oncology Meeting, Barcelona, Spain Sep 28 2019 Notes: Poster presentation.